The Enterprise Genomics Platform
Helix transforms health organizations to leverage the power of genomics across their enterprise, creating strategic value and fueling future growth.

Helix Research Network
Accelerate genomic discoveries and drive real-world clinical impact. Leverage collective genomic intelligence to advance precision medicine, enhance patient care, and lead in healthcare innovation.
Helix Precision Pathway
Utilize Helix's advanced genomic insights that enhance clinical decision-making and improve patient outcomes. Empower your healthcare organization to deliver personalized care at scale.
Helix Diagnostics
Unlock comprehensive genomic insights with Helix Diagnostics. Simplify genetic testing for your patients while gaining actionable health information.
Helix Genomic Advantage
Harness Helix Genomic Advantage to shift the cost curve and drive growth for health plans. Reduce healthcare spend while improving member outcomes.
Driving Collaboration and Partnership Across Industries
committed across 15+ HRN members

Transforming healthcare delivery and planning with genetic insights, empowering health systems to enhance patient outcomes and drive population health initiatives.
Empowering Precision Health at an Enterprise Scale
"Helix integrates genomics into everyday healthcare, enabling organizations to implement precision medicine effectively. We transform genetic insights into practical health strategies, improving patient care while optimizing operational efficiency and expanding clinical capabilities."
Accelerate Strategic Growth
Our solutions enable the expansion of precision medicine capabilities, driving patient engagement, improving health outcomes, and creating new revenue streams through innovative genomic offerings.
Diversify Revenue Streams
Expand beyond genetic testing to offer personalized health programs, targeted screenings, and data-driven services, creating ongoing patient engagement and value-based care opportunities.
Managing Total Cost of Care
Transform healthcare economics through genomic intelligence. Identify high-risk populations and enable targeted interventions, reducing unnecessary treatments while improving outcomes.
Partner Perspectives
The Latest Helix Resources
Cincinnati Magazine: TriHealth Partners with Helix to Launch Clinical Genomics Study
From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care
Helix and Veracyte collaborate to expand access to combined germline and tumor transcriptomic testing through an integrated clinical workflow
Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care
Collaboration brings whole-exome based hereditary cancer insights to urologists and their patients by offering it alongside Veracyte’s Decipher Prostate Test